Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Polyangiitis overlap syndrome]

K Tanimoto1

  • 1Health Service Center, University of Saitama.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1994
PubMed
Summary
This summary is machine-generated.

Polyangiitis overlap (PO) syndrome describes patients with systemic manifestations of multiple vasculitis diseases. Effective treatment with corticosteroid and cyclophosphamide often leads to remission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tongue-palatal contact changes in patients with skeletal mandibular prognathism after sagittal split ramus osteotomy: an electropalatography study.

Journal of oral rehabilitation·2017
Same author

Simple Synthesis of Both Enantiomers of the C7-C12 Segment of Epothilones.

Bioscience, biotechnology, and biochemistry·2016
Same author

The effect of magnetic field during freezing and thawing of rat bone marrow-derived mesenchymal stem cells.

Cryobiology·2016
Same author

The C-terminus of amelogenin enhances osteogenic differentiation of human cementoblast lineage cells.

Journal of periodontal research·2016
Same author

The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation.

Oncogene·2015
Same author

Attenuation of pain behaviour by local administration of alpha-2 adrenoceptor antagonists to dorsal root ganglia in a rat radiculopathy model.

European journal of pain (London, England)·2015
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Context:

  • Polyangiitis overlap (PO) syndrome, first described in 1986, is a diagnostic category for patients presenting with systemic manifestations of multiple vasculitis conditions.
  • It encompasses cases that do not fit into a single established vasculitis entity, including unclassified systemic necrotizing vasculitis.

Purpose:

  • To define and characterize Polyangiitis overlap (PO) syndrome.
  • To identify common combinations and treatment outcomes for this complex vasculitis syndrome.

Summary:

  • PO syndrome is characterized by overlapping systemic manifestations of established vasculitis diseases.
  • The most frequent combination involves classical polyarteritis nodosa and Churg-Strauss syndrome.
  • Prognosis is generally favorable, with most patients achieving remission.

Related Experiment Videos

Impact:

  • Clarifies diagnostic criteria for complex vasculitis cases.
  • Highlights the efficacy of corticosteroid and cyclophosphamide in managing PO syndrome.
  • Improves understanding of vasculitis heterogeneity and patient management strategies.